Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Liabilities and Shareholders Equity (2019 - 2026)

Cresco Labs filings provide 8 years of Liabilities and Shareholders Equity readings, the most recent being $1.2 billion for Q1 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 12.11% to $1.2 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $5.0 billion, a 7.99% decrease, with the full-year FY2025 number at $1.2 billion, down 11.66% from a year prior.
  • Liabilities and Shareholders Equity hit $1.2 billion in Q1 2026 for Cresco Labs, roughly flat from $1.2 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $1.8 billion in Q1 2022 to a low of $1.2 billion in Q4 2025.
  • Median Liabilities and Shareholders Equity over the past 5 years was $1.4 billion (2025), compared with a mean of $1.4 billion.
  • Biggest five-year swings in Liabilities and Shareholders Equity: increased 26.85% in 2022 and later decreased 20.33% in 2023.
  • Cresco Labs' Liabilities and Shareholders Equity stood at $1.6 billion in 2022, then fell by 14.22% to $1.4 billion in 2023, then fell by 0.23% to $1.4 billion in 2024, then dropped by 11.66% to $1.2 billion in 2025, then grew by 0.13% to $1.2 billion in 2026.
  • The last three reported values for Liabilities and Shareholders Equity were $1.2 billion (Q1 2026), $1.2 billion (Q4 2025), and $1.3 billion (Q3 2025) per Business Quant data.